Rajesh MagowDirector · Group Chief Executive Officer
4
Filed Nov 5, 2026Period of report Nov 3, 20260001193125-26-448845
| Transaction | Security | Shares | Price | ValueValue (shares × price) | Held after | Ownership |
|---|---|---|---|---|---|---|
SaleNov 4, 2026 | Ordinary SharesF2 | 10,000 | $50.11 | $501.10K | 0 | Direct |
SaleNov 3, 2026 | Ordinary SharesF1 | 20,000 | $45.25 | $905.00K | 0 | Direct |
Filing footnotes · 4
- F1The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions at prices ranging from $45.20 to $45.45. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote.
- F2The price reported in Column 4 is a weighted average price. These ordinary shares were sold in multiple transactions at prices ranging from $50.01 to $50.37. The reporting person undertakes to provide the Company, any shareholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares sold at each separate price within the range set forth in this footnote.
- F3Following the transaction dated November 3, 2026, 1,384,185 Restricted Stock Units (RSUs) are vested, with expiration dates ranging from March 31, 2028 to June 30, 2031 unless extended at the sole discretion of the Company. In addition, 29,478 RSUs remain unvested and are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based RSUs relating to 14,739 ordinary shares subject to the achievement of certain performance-based vesting conditions.
- F4Following the transaction dated November 4, 2026, 1,374,185 RSUs are vested, with expiration dates ranging from March 31, 2028 to June 30, 2031 unless extended at the sole discretion of the Company. In addition, 29,478 RSUs remain unvested and are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based RSUs relating to 14,739 Ordinary Shares subject to the achievement of certain performance-based vesting conditions.